Otsuka Holdings Co., Ltd. (OTSKF)

Market Cap	33.90B +20.8%
Revenue (ttm)	15.75B +6.0%
Net Income	2.32B +5.8%
EPS	4.37 +8.1%
Shares Out	n/a
PE Ratio	14.64
Forward PE	n/a
Dividend	0.93 (1.39%)
Ex-Dividend Date	Dec 29, 2025

Volume	n/a
Average Volume	1,102
Open	67.11
Previous Close	67.11
Day's Range	67.11 - 67.11
52-Week Range	44.40 - 70.19
Beta	-0.13
RSI	65.12
Earnings Date	Feb 13, 2026

About Otsuka Holdings

Otsuka Holdings Co., Ltd. engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide. The company develops pharmaceutical products in the fields of psychiatry, neurology, oncology, cardiovascular and renal system, digestive system, ophthalmology, and diagnostics, as well as intravenous solutions and medical devices. It also provides clinical testing, medical equipment and tools, food products, cosmetics, functional food products, chemical products, soft drinks, beverages, analytical and measurement equipme...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1921
• Employees: 35,338
• Stock Exchange: OTCMKTS
• Ticker Symbol: OTSKF

Financial Performance

In 2025, Otsuka Holdings's revenue was 2.47 trillion, an increase of 5.97% compared to the previous year's 2.33 trillion. Earnings were 363.15 billion, an increase of 5.84%.

Financial numbers in JPY